Free Trial

Astellas Pharma (ALPMY) News Today

Astellas Pharma logo
$11.66
-0.02 (-0.17%)
(As of 11/1/2024 ET)
Astellas Pharma H1 Profit Rises; Lifts FY24 Outlook
Astellas Pharma Inc. (OTCMKTS:ALPMY) Short Interest Update
Astellas Pharma Inc. stock logo
Astellas Pharma Inc. (OTCMKTS:ALPMY) Sees Significant Growth in Short Interest
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) saw a large increase in short interest in October. As of October 15th, there was short interest totalling 45,100 shares, an increase of 16.2% from the September 30th total of 38,800 shares. Based on an average trading volume of 182,400 shares, the days-to-cover ratio is presently 0.2 days.
Astellas Pharma Withdraws EU Application for Key Drug
Bernstein Releases a Buy Rating on Astellas Pharma (ALPMF)
Astellas Pharma’s VYLOY Gains FDA Approval for Cancer Treatment
Astellas Pharma's Cancer Drug Vyloy Gets FDA Approval
FDA approves Astellas' gastric cancer therapy
Astellas Pharma Inc. stock logo
Astellas Pharma Inc. (OTCMKTS:ALPMY) Sees Large Growth in Short Interest
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 38,800 shares, an increase of 269.5% from the September 15th total of 10,500 shares. Based on an average trading volume of 139,900 shares, the short-interest ratio is currently 0.3 days.
Astellas Receives Option To License AVB-101 - Quick Facts
Astellas Pharma Inc. stock logo
Astellas Pharma Inc. (OTCMKTS:ALPMY) Sees Significant Decrease in Short Interest
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) was the target of a large drop in short interest in the month of September. As of September 15th, there was short interest totalling 10,500 shares, a drop of 75.4% from the August 31st total of 42,600 shares. Based on an average daily volume of 201,200 shares, the days-to-cover ratio is presently 0.1 days.
Astellas Announces FDA Listing Of DIGITIVA For Heart Failure Management
Astellas opens lab, offices in Cambridge Crossing
Santen Pharmaceutical Co., Ltd. (SZD.F)
Astellas Pharma Inc. stock logo
Astellas Pharma Inc. (OTCMKTS:ALPMY) Short Interest Down 11.9% in July
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) saw a large decrease in short interest in July. As of July 31st, there was short interest totalling 298,700 shares, a decrease of 11.9% from the July 15th total of 338,900 shares. Based on an average daily trading volume, of 530,700 shares, the days-to-cover ratio is currently 0.6 days.
Astellas Pharma Inc. stock logo
Astellas Pharma (OTCMKTS:ALPMY) Share Price Crosses Above 50 Day Moving Average of $10.38
Astellas Pharma (OTCMKTS:ALPMY) Stock Price Crosses Above 50-Day Moving Average of $10.38
Astellas Pharma Inc. stock logo
Astellas Pharma (OTCMKTS:ALPMY) Share Price Crosses Above 50-Day Moving Average of $10.18
Astellas Pharma (OTCMKTS:ALPMY) Stock Price Crosses Above 50 Day Moving Average of $10.18
Astellas Pharma Inc. stock logo
Short Interest in Astellas Pharma Inc. (OTCMKTS:ALPMY) Decreases By 10.5%
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) was the target of a significant drop in short interest in the month of June. As of June 30th, there was short interest totalling 227,800 shares, a drop of 10.5% from the June 15th total of 254,500 shares. Based on an average daily volume of 518,500 shares, the short-interest ratio is currently 0.4 days.
Astellas Pharma Inc. stock logo
Astellas Pharma Inc. (OTCMKTS:ALPMY) Short Interest Up 83.5% in June
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 254,500 shares, an increase of 83.5% from the May 31st total of 138,700 shares. Based on an average daily volume of 839,200 shares, the short-interest ratio is presently 0.3 days.
Astellas Pharma Inc. stock logo
Short Interest in Astellas Pharma Inc. (OTCMKTS:ALPMY) Expands By 87.2%
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) saw a large increase in short interest in May. As of May 31st, there was short interest totalling 138,700 shares, an increase of 87.2% from the May 15th total of 74,100 shares. Based on an average daily trading volume, of 647,900 shares, the short-interest ratio is presently 0.2 days.
Astellas Pharma Inc. stock logo
Astellas Pharma Inc. (OTCMKTS:ALPMY) Short Interest Down 11.7% in May
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 74,100 shares, a decrease of 11.7% from the April 30th total of 83,900 shares. Based on an average daily volume of 564,700 shares, the short-interest ratio is presently 0.1 days.
Get Astellas Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALPMY and its competitors with MarketBeat's FREE daily newsletter.

625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

ALPMY Media Mentions By Week

ALPMY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALPMY
News Sentiment

1.19

0.43

Average
Medical
News Sentiment

ALPMY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALPMY Articles
This Week

6

2

ALPMY Articles
Average Week

Get Astellas Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALPMY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:ALPMY) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners